39 results about "Hepatic disposition" patented technology

The invention provides a slow-release preparation of ornithine aspartate, the slow-release preparation comprises major components of the ornithine aspartate and an auxiliary additive, and controlled release of active ingredients in the preparation can be realized by the auxiliary additive. The preparation prepared into a capsule preparation formulation overcomes the defects that other ornithine aspartate preparations such as an injection are high in concentration, inconvenient to store and transport, and difficult to use for a patient by oneself, and the preparation has the advantages of convenience for middle and old age patients to take, quick absorption, high biological utilization rate and the like. The slow-release preparation of the ornithine aspartate is suitable for blood ammonia rising caused by acute and chronic liver diseases (such as various types of hepatitis, liver cirrhosis, fatty liver and post-hepatitis syndrome) and treatment of hepatic encephalopathy such as potential or attack-stage hepatic encephalopathy accompanying with or secondary with liver detoxification function damage (such as liver cirrhosis), and is especially suitable for the treatment of consciousness clouding state and other diseases in an early hepatic coma period and a hepatic coma period.